Recombinant adenoviral vector-lipofectAMINE complex for gene transduction into human T lymphocytes

Human Gene Therapy

Volumn 10, Issue 11, 1999, Pages 1875-1884

  Di Nicola, Massimo ^a,e   Milanesi, Marco ^a   Magni, Michele ^a   Bregni, Marco ^b   Carlo Stella, Carmelo ^a   Longoni, Paolo ^a   Tomanin, Rosella ^c   Ravagnani, Fabrizio ^a   Scarpa, Maurizio ^c   Jordan, Craig ^d   Gianni, A Massimo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF KENTUCKY   (United States)

^e C Gandini Bone Marrow T   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 7; LIPOFECTAMINE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL FRACTIONATION; CELL SUBPOPULATION; FLOW CYTOMETRY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; REPORTER GENE; T LYMPHOCYTE; TRANSGENE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ALKALINE PHOSPHATASE; ANTIGENS, CD3; CATION EXCHANGE RESINS; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERLEUKIN-2; INTERLEUKIN-7; LIPID METABOLISM; LIPIDS; LYMPHOCYTE ACTIVATION; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

ADENOVIRIDAE;

EID: 0033587490     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017554     Document Type: Article

References (32)

1. ATKINSON, K., HOROWITZ, M.M., GALE, R.P., VAN BEKKUM, D.W., GLUCKMAN, E., GOOD, R.A., JACOBSEN, N., KOLB, H.J., RIMM, A.A., RINGDEN, O, ROZMAN, C., SOBOCINSKI, K.A., ZWAAN, F.E., and BORTIN, M.M. (1990). Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75, 2459-2464.
2. BAJETTA, E., DEL VECCHIO, M., MORTARINI, R., NADEAU, R., RAKHIT, A., RIMASSA, L., FOWST, C., BORRI, A., ANICHINI, A., and PARMIANI, G. (1998). Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma. Clin. Cancer Res. 4, 75-85.
3. BERGELSON, J.M., CUNNINGHAM, J.A., DROGUETT, G., KURTJONES, E.A., KRITHIVAS, A., HONG, J.S., HORWITZ, M.S., CROWELL, R.L., and FINBERG, R.W. (1997). Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320-1323.
4. BONINI, C., FERRARI, G., VERZELLETTI, S., SERVIDA, P., ZAPPONE, E., RUGGIERI, L., PONZONI, M., ROSSINI, S., MAVILIO, F., TRAVERSARI, C., and BORDIGNON, C. (1997). HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science 276, 1719-1724.
5. BORDIGNON, C., NOTARANGELO, L.D., NOBILI, N., FERRARI, G., CASORATI, G., PANINA, P., MAZZOLARI, E., MAGGIONI, D., ROSSI, C., UGAZIO, A.U., and MAVILIO, F. (1995). Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270, 470-475.
6. BREGNI, M., MAGNI, M., SIENA, S., DI NICOLA, M., BONADONNA, G., and GIANNI, A.M. (1994). Human peripheral blood hematopoietic progenitors are optimal targets of retroviral mediated gene transfer. Blood 80, 1418-1422.
7. + cells. Gene Ther. 5, 465-472.
8. BUNNELL, B.A., MESLER MUUL, L., DONAHUE, R.E., BLAESE, R.M., and MORGAN, R.A. (1995). High efficiency retroviral mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 7739-7743.
9. CARLO-STELLA, C., REGAZZI, E., GARAU, D., MANGONI, L., RIZZO, M.T., BONATI, A., DOTTI, G., ALMICI, C., and RIZZOLI, V. (1996). Effect of the protein tyrosine kinase inhibitor genistein on normal and leukemic hematopoietic progenitor cell growth. Br. J. Haematol. 93, 551-557.
10. CHOUAIB, S., CHEHIMI, J., BANI, L., GENETET, N., TURSZ, T., GAY, F., TRINCHIERI, G., and MAMI-CHOUAIB, F. (1994). Interleukin 12 induces the differentiation of major istocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effettors. Proc. Natl. Acad. Sci. U.S.A. 91, 12659-12663.
11. CRYSTAL, R.G. (1995). Transfer of genes to human: Early lessons and obstables to success. Science 270, 404-410.
12. + cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood 89, 4040-4046.
13. FASBENDER, A., ZABNER, J., CHILLON, M., MONINGER, T.O., PUGA, A.P., DAVIDSON, B.L., and WELSH, M.J. (1997). Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J. Biol. Chem. 272, 6479-6489.
14. FERRARA, J.L., COOKE, K.R., PAN, L., and KRENGER, W. (1996). The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 14, 473-489.
15. FREY, B.M. HACKETT, N.R., BERGELSON, J.M., FINBERG, R., CRYSTAL, R.G., MOORE, M.A.S., and RAFII, S. (1998). High efficiency gene transfer into ex-vivo expanded human hematopoietic progenitors and precursor cell by adenovirus vectors. Blood 91, 2781-2792.
16. GRAHAM, F.L., and PREVEC, L. (1992). Adenovirus-based expression vectors and recombinant vaccines. Bio/Technology 20, 363-390.
17. 5 on human monocytes and T-lymphocytes facilitates adenovirus-mediated gene delivery. J. Virol. 69, 2257-2263.
18. KAPLAN, J.M., PENNINGTON, S.E., ST. GEORGE, J.A., WOODWORTH, L.A., FASSENDER, A., MARSHALL, J., CHENG, S.H., WADSWORTH, S.C., GREGORY, R.J., and SMITH, A.E. (1998). Potentation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential. Hum. Gene Ther. 9, 1469-1479.
19. KOZARSKY, K.F., and WILSON, J.M. (1993). Gene therapy: Adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503.
20. LINK, C.J., BURT, R.K., TRAYNOR, A.E., DROBYSKI, W.R., SEREGINA, T., LEVY, J.P., GORDON, L., ROSEN, S.T., BURNS, W.H., CAMITTA, B., CASPER, J., HOROWITZ, M., JUCKETT, M., LAWTON, C., MARGOLIS, D., PIETRYGA, D., ROWLINGS, P., TAYLOR, C., FURTADO, M., STEFKA, I., GUPTA-BURT, S., KAISER, H., and VESOLE, D.H. (1998). Adoptive immunotherapy for leukemia: Donor lymphocytes transduced with the herpes simplex thymidine kinase gene for remission induction. Hum. Gene Ther. 9, 115-134.
21. LYNCH, D.H., and MILLER, R.E. (1994). Interleukin 7 promotes long-term in vivo growth of antitumor cytoxic T-lymphocytes with immunotherapeutic efficacy in vivo. J. Exp. Med. 179, 31-42.
22. MAVILIO, F., FERRARI, G., ROSSINI, S., NOBILI, N., BONINI, C., CASORATI, G., TRAVERSARI, C., and BORDIGNON, C. (1994). Peripheral blood lymphocytes as target cells of retroviral vector-mediated gene transfer. Blood 83, 1988-1997.
23. MITANI, K., GRAHAM, F.L., and CASKEY, T. (1994). Transduction of human bone marrow by adenoviral vector. Hum. Gene Ther. 5, 941-948.
24. NEERING, S.J., HARDY, S.F., MINAMOTO, D., SPRATT, S.K., and JORDAN, C.T. (996). Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 88, 1147-1155.
25. QIU, C., DE YOUNG, M.B., FINN, A., and DICHEK, D.A. (1998). Cationic liposomes enhance adenovirus entry via a pathway independent of the fiber receptor and alpha(v)-integrins. Hum. Gene Ther. 9, 507-520.
26. ROBINET, E., CERTOUX, J.M., FERRAND, C., MAPLES, P., HARDWICK, A., CAHN, J.Y., REYNOLDS, C.W., JACOB, W., HERVÉ, P., and TIBERGHIEN, P. (1998). A closed culture system for the ex-vivo transduction and expansion of human T-lymphocytes. J. Hematother. 7, 205-215.
27. SHARMA, S., WAWNG, J., HUANG, M., PAUL, R.W., LEE, P., McBRIDE, W.H., ECONOMOU, J.S., ROTH, M.D., KIERTSCHER, S.M., and DUBINETT, S.M. (1996). Interleukin-7 gene transfer in non-small-cell cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity. Cancer Gene Ther. 3, 302-313.
28. STADLER, W.M., KUZEL, T., DUMAS, M., and VOGELZANG, N.J. (1998). Multicenter phase I trial of interleukin-2, interferon-alpha, and 13-cis-retinoic in patients with metastatic renal-cell carcinoma. J. Clin. Oncol. 16, 1820-1825.
29. STORE, R., PRENTICE, R.L., SULLIVAN, K.M., SHULMAN, H.M., DEEG, H.J., DONEY, K.C., BUCKNER, C.D., CLIFT, R.A., WITHERSPOON, R.P., APPELBAUM, F.A., SANDERS, J.E., STEWART, P.S., and THOMAS, E.D. (1983). Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann. Intern. Med. 98, 461-466.
30. WEIJTENS, M.E.M., WILLEMSEN, R.A., VAN KRIMPEN, B.A., and BOLHIUS, R.L.H. (1998a). Chimeric scFv/g receptor-mediated T-cell lysis of tumor cells is coregulated by adhesion and accessory molecules. Int. J. Cancer 77, 181-187.
31. WEIJTENS, M.E.M., WILLEMSEN, R.A., HART, E.H., and BOLHIUS, R.L.H. (1998b). A retroviral vector system "STITCH" in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T-lymphocytes. Gene Ther. 5, 1195-1203.
32. YANG, Y., NUNES, F.A., BERENCSI, K., GONCZOL, E., ENGELHARDT, J.E., and WILSON, J.M. (1994). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.